In a 2018 report by Enhorning et al. [18], elevated serum copeptin (reflecting a high AVP state) in two population-based cohorts with follow ups of 8.7 and 19.6 years effectively predicted the risk of CKD development. This evidence concerns the gene AVP and chronic kidney disease.